Since changes to NSW legislation came into effect on 1 August 2016, medical practitioners have been able to apply to NSW Health for authority to prescribe and supply Schedule (S8) cannabis medicines, including those not on the Australian Register of Therapeutic Goods (ARTG).

Products containing only the Schedule 4 substance cannabidiol do not require a NSW Health authority therefore data is not held by the Ministry of Health.

In the period 1 August 2016 to 30 September 2018, NSW Health received 801 applications for authority to prescribe and supply S8 cannabis medicines (including registered and unregistered products) for the treatment of individual patients. These figures exclude treatment of individuals as part of a clinical trial.

Figure 1 below shows the cumulative number of applications to prescribe a S8 cannabis medicine received for the period 1 August 2016 to 30 September 2018.

 

Cumulative number of applications received to treat an individual patient with a cannabis product, for the period 1 August 2016, text alternative follows image Source: NSW Ministry of Health (2/11/18) 

Text alternative

Figure 2 below shows the outcome of applications received to prescribe a S8 cannabis medicine for the period 1 August 2016 to 30 September 2018.

 

Outcome of applications received to treat an individual patient with a cannabis product, for the period 1 August 2016 to 30 Sept, text alternative follows image 
Source: NSW Ministry of Heath (2/11/18) 

Text alternative​

Note that where an application is incomplete the Ministry requests further information from the prescriber to enable the application to be considered. In some cases the prescriber chooses to withdraw an application.
Page Updated: Thursday 29 November 2018
Contact page owner: Pharmaceutical Services